| Age at exposure | Age at outcome | Obs.* | PAR (95% CI) | EAC (95% CI) |
|---|---|---|---|---|
| Men | ||||
| 20-34 | 30-44 | < 5 | 11.7 (8.3-15.2) | - |
| 35-49 | 45-59 | 14 | 7.9 (5.4-10.7) | 1 (1-2) |
| 50-64 | 60-74 | 47 | 6.6 (4.3-9.3) | 3 (2-5) |
| ≥ 65 | ≥ 75 | 33 | 3.6 (2.0-5.7) | 1 (1-2) |
| Total | Total | < 99 | 5 | |
| Women | ||||
| 20-34 | 30-44 | < 5 | 8.1 (5.7-10.8) | - |
| 35-49 | 45-59 | 17 | 6.6 (4.3-9.2) | 1 (1-2) |
| 50-64 | 60-74 | 48 | 4.7 (3.0-6.7) | 2 (1-3) |
| ≥ 65 | ≥ 75 | 34 | 3.7 (2.4-5.4) | 1 (1-2) |
| Total | Total | < 104 | 4 | |
| Total | ||||
| 20-34 | 30-44 | < 5 | 9.9 (7.1-12.9) | - |
| 35-49 | 45-59 | 31 | 7.3 (5.0-9.6) | 2 (1-3) |
| 50-64 | 60-74 | 95 | 5.5 (3.7-7.4) | 5 (3-7) |
| ≥ 65 | ≥ 75 | 67 | 3.7 (2.4-5.2) | 2 (2-4) |
| Total | Total | < 198 | 9 |
Note: CI = confidence interval, EAC = excess attributable cases due to exposure, Obs. = total number of observed cases per age-sex group, PAR = population attributable risk.
*Cell counts of less than 5 for observed cases were suppressed to comply with confidentiality requirements.